Diphenhydramine
Diphenhydramine is a pharmaceutical drug with 130 clinical trials. Currently 20 active trials ongoing. Historical success rate of 80.6%.
Success Metrics
Based on 75 completed trials
Phase Distribution
Phase Distribution
39
Early Stage
44
Mid Stage
32
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
77.3%
75 of 97 finished
22.7%
22 ended early
20
trials recruiting
130
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
Diphenhydramine as an Adjunct to Moderate Sedation for Procedural First Trimester Abortions
A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure
Chicago Social Drinking Project
Clinical Trials (130)
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
Diphenhydramine as an Adjunct to Moderate Sedation for Procedural First Trimester Abortions
A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure
Chicago Social Drinking Project
Trial of Diphenhydramine for Sleep in Children With Autism
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
TReatment for ImmUne Mediated PathopHysiology
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Stem Cell Transplantation in Crohn's Disease
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer
Intranasal Ketorolac Trial
A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 130